乌鸦传媒

<乌鸦传媒 class='mpt-top_cat_title'>Gastroenterology >

Pancreatic Diseases

News, opinions and meeting coverage in gastroenterology.

<乌鸦传媒>ACG: Focus on the Practical at Annual Meeting

Topics will range from gluten contamination to artificial intelligence for polyp detection

<乌鸦传媒>Microbiome Dysbiosis Promotes Pancreatic Disease

Microbiome check may benefit those at risk for pancreatitis and cancer

<乌鸦传媒>Pancreatic Ca Gets 20-Month Survival Boost

Aggressive post-surgery chemo regimen touted as new standard of care

<乌鸦传媒>Pre-Surgical CRT May Boost Survival in Pancreatic Ca

Further data needed to clarify best approach and who would benefit most

<乌鸦传媒>Pancreatitis Raises Risk of Later Cancer

Likelihood of pancreatic cancer increased beyond 5 years after the acute episode

<乌鸦传媒>Snus Cleared of Pancreatic Cancer Risk

Pooled data contradict earlier analysis

<乌鸦传媒>ESTRO: Survival in Pancreatic Ca Rises with RT Dose

Also: cartoons during RT, brachytherapy for penile cancer

<乌鸦传媒>DDW 2017: Diversity Will Be Meeting's Strength

Four-society meeting has plenty to offer across and among specialties

<乌鸦传媒>FDA Issues Warning on IBS Drug Viberzi

Must be avoided in patients whose gallbladders have been removed

<乌鸦传媒>ECC Roundup: Breast Conservation Benefit Varies by Age

And other reports from the European Cancer Congress

<乌鸦传媒>Fraud Rounds: Grant Fakery Earns Practice Ban

Cancer researcher struck from U.K. medical register after fabricating data in grant applications

<乌鸦传媒>Victoza Accused of Causing Pancreatitis

The watchdog group Public Citizen has conducted its own analysis of FDA adverse event reports and concluded that the type 2 diabetes drug liraglutide(Victoza) likely causes pancreatitis, the group said.

<乌鸦传媒>Combo Active in Neuroendocrine Cancers

SAN FRANCISCO -- More than 90% of patients with neuroendocrine tumors had objective responses or stable disease when treated with an off-the-shelf chemotherapy doublet, results of a small study showed.

<乌鸦传媒>FDA Panel Rejects Cystic Fibrosis Drug

SILVER SPRING, Md. -- An FDA advisory committee has voted against approval of liprotamase (Sollpura), a pancreatic enzyme product for cystic fibrosis and other diseases that cause pancreatic insufficiency, saying there is not enough evidence that the drug works better than agents already on the market.

<乌鸦传媒>Rare Complication Leaves Gastric Bypass Patients Almost Disabled

ROCHESTER, Minn.-A rare complication of Roux-en-Y gastric bypass surgery is hyperfunction of insulin-producing beta cells, which causes potentially life-threatening neuroglycopenia, say Mayo clinicians.